BioCryst Reports Third Quarter 2016 Financial Results
RESEARCH TRIANGLE PARK, N.C., Nov. 07, 2016 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial results for the third quarter ended September 30, 2016. “Our company’s primary focus is on the execution of the APeX-1 …